2023 annual financial data
Processa Pharmaceuticals, Inc. 2023 Operating margin
Processa Pharmaceuticals, Inc. 2023 operating margin with verified reported val…
Direct answer
Operating margin was Not calculable.
Operating income was -11,457,061 USD and net income was -11,121,520 USD.
Operating cash flow was -8,063,346 USD.
Get free Processa Pharmaceuticals, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,457,061 USD
- Net income
- -11,121,520 USD
- Operating cash flow
- -8,063,346 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Processa Pharmaceuticals, Inc. financial years